World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
42
Citations
12528
World Ranking
4866
National Ranking
2178

Jane L. Grogan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jane L. Grogan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 80 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jane L. Grogan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jane L. Grogan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 42 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jane L. Grogan is affiliated with Biogen in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a particular focus on Oncology, Immunology, Molecular Biology, Genetics, and Plant Science as notable subfields of study.

The scientist's work concentrates on topics including CAR-T cell therapy research, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, CRISPR and Genetic Engineering, Immune cells in cancer, RNA and protein synthesis mechanisms, and Virus-based gene therapy research.

Jane L. Grogan has contributed to multiple publications, with recent notable papers as follows:

  • Peripheral T cell expansion predicts tumour infiltration and clinical response, 2020, Nature
  • High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade, 2020, Nature Medicine
  • Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer, 2022, Cancer Cell
  • Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses, 2022, Immunity
  • Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade, 2021, Journal for ImmunoTherapy of Cancer

The scientist frequently publishes in the following venues:

  • European Journal of Immunology
  • Nature Medicine
  • Cancer Research
  • Nature Communications
  • Nature

Frequent co-authors who have collaborated on multiple publications with Jane L. Grogan include:

  • Avantika S. Chitre
  • Sophie Brouard
  • Dirk H. Busch
  • Andrea Cossarizza
  • Günnur Deniz

Best Publications

  • The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.

    Xin Yu;Kristin Harden;Lino C Gonzalez;Michelle Francesco

  • The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function

    Robert J. Johnston;Laetitia Comps-Agrar;Jason Hackney;Xin Yu

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs

  • Human fetal lymphoid tissue–inducer cells are interleukin 17–producing precursors to RORC + CD127 + natural killer–like cells

    Tom Cupedo;Natasha K Crellin;Natalie Papazian;Elwin J Rombouts

  • Peripheral T cell expansion predicts tumour infiltration and clinical response

    Thomas D. Wu;Shravan Madireddi;Patricia E. de Almeida;Romain Banchereau

  • T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function

    Max Löhning;Arne Stroehmann;Anthony J. Coyle;Jane L. Grogan

  • Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets.

    Jane L. Grogan;Markus Mohrs;Brian Harmon;Dee A. Lacy

  • Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses

    Unknown

  • TIGIT: A Key Inhibitor of the Cancer Immunity Cycle.

    Nicholas A. Manieri;Eugene Y. Chiang;Jane L. Grogan

  • High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade.

    Kobe C. Yuen;Li-Fen Liu;Vinita Gupta;Shravan Madireddi

  • Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice

    Janet Lau;Jeanne Cheung;Armando Navarro;Steve Lianoglou

  • Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer

    Unknown

  • Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease.

    Eugene Y Chiang;Ganesh A Kolumam;Xin Yu;Michelle Francesco

  • Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell–cell adhesion and signaling mechanism that requires cis-trans receptor clustering

    Katharina F. Stengel;Kristin Harden-Bowles;Xin Yu;Lionel Rouge

  • TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers

    X Yu;R Pappu;V Ramirez-Carrozzi;N Ota

  • Modulation of blood fluke development in the liver by hepatic CD4+ lymphocytes.

    Stephen J. Davies;Jane L. Grogan;Rebecca B. Blank;K. C. Lim

  • T helper cell differentiation: on again, off again

    Jane L Grogan;Richard M Locksley

  • CD30 expression does not discriminate between human Th1- and Th2-type T cells.

    D. Hamann;C. M. U. Hilkens;J. L. Grogan;S. M. A. Lens

  • Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.

    Romain Banchereau;Avantika S. Chitre;Alexis Scherl;Thomas D. Wu

  • Antigen-Specific Proliferation and Interferon-γ and Interleukin-5 Production Are Down-Regulated during Schistosoma haematobium Infection

    Jane L. Grogan;Peter G. Kremsner;André M. Deelder;Maria Yazdanbakhsh

  • Elevated proliferation and interleukin-4 release from CD4+ cells after chemotherapy in human Schistosoma haematobium infection

    Jane L. Grogan;Peter G. Kremsner;Peter G. Kremsner;Andre M. Deelder;Maria Yazdanbakhsh

  • CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment.

    Hélène Bour-Jordan;Jane L. Grogan;Qizhi Tang;Qizhi Tang;Julie A. Auger

Frequent Co-Authors

Dan L. Eaton
Dan L. Eaton Genentech
Maria Yazdanbakhsh
Maria Yazdanbakhsh Leiden University Medical Center
Peter G. Kremsner
Peter G. Kremsner University of Tübingen
Zora Modrusan
Zora Modrusan Genentech
Wenjun Ouyang
Wenjun Ouyang Amgen (United States)
Ira Mellman
Ira Mellman Parker Institute for Cancer Immunotherapy
Jenny Mjösberg
Jenny Mjösberg Karolinska Institute
Simon Fillatreau
Simon Fillatreau Université Paris Cité
Andreas Radbruch
Andreas Radbruch German Rheumatism Research Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens the door to various healthcare roles, many of which align well with nursing and advanced practice careers. For professionals interested in advancing their clinical expertise, exploring an fnp to acnp bridge program online can facilitate a smooth transition to acute care nursing, complementing immunology knowledge with specialized patient care skills.

Those seeking to expedite their nursing credentials might consider an accelerated nurse practitioner program, which offers a fast track to becoming a nurse practitioner while integrating essential scientific insights, including immunology concepts critical for patient treatment and care.

For individuals new to nursing, several online rn programs for non nurses in florida provide accessible pathways to obtain RN licensure. These programs often include foundational coursework that supports understanding immune system functions, benefiting future specialization in immunology-related healthcare fields.

Additionally, finding the right fit is important, and many students start with easiest accelerated nursing programs to get into, which offer flexible entry points for busy learners. These programs help build essential nursing competencies that complement immunology studies, making them ideal for those aiming for a rapid career start in health sciences.

Best Scientists Citing Jane L. Grogan

Trending Scientists

Recently Published Articles